Hualan Biological Bacterin Inc. (301207): Kapitalflussrechnung
| Preis (11.09.2026) | 52W Hoch | 52W Tief |
| 17,22 Renminbi Yuan | 26,612 Renminbi Yuan | 15,43 Renminbi Yuan |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 25,565 Renminbi Yuan | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 601.027.500 | - | - |
Kennzahl in 1000 CNY | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
|---|---|---|---|---|---|---|---|---|---|
Umsatz | 1.202.505,821 | 1.127.812,323 | 2.410.428,457 | 1.825.640,965 | 1.829.813,885 | 2.426.328,945 | 1.048.988,2 | 802.738,2 | 284.911,4 |
Cashflow aus operativer Geschäftstätigkeit | 357.132,205 | 468.041,442 | 888.024,961 | 288.662,214 | 569.328,674 | 693.711,957 | 275.040,98 | 94.456,132 | 22.171,564 |
▸ Operative Cashflow Marge | 29,7% | 41,5% | 36,84% | 15,81% | 31,11% | 28,59% | 26,22% | 11,77% | 7,78% |
Investitionsausgaben (CapEx) | 9.703,312 | 51.595,887 | 62.601,193 | 92.647,237 | 636.060,325 | 532.284,37 | 143.894,235 | 62.767,961 | 25.598,125 |
Cashflow aus Investitionstätigkeit | - | -61.079,858 | -773.714,856 | -1.755.650,533 | -1.091.865,693 | -753.326,11 | -140.515,825 | 21.186,81 | 59.011,832 |
Cashflow aus Finanzierungstätigkeit | - | -424.822,352 | -126.086,333 | 1.952.237,131 | 286.134,305 | 135.693,102 | - | - | -100.000 |
Freier Cashflow | 347.428,893 | 416.445,555 | 825.423,768 | 196.014,977 | -66.731,65 | 161.427,587 | 131.146,745 | 31.688,171 | -3.426,561 |
▸ Freie Cashflow Marge | 28,89% | 36,93% | 34,24% | 10,74% | -3,65% | 6,65% | 12,5% | 3,95% | -1,2% |
Ausgeschüttete Dividenden | -507.893,36 | -334.316,5 | -126.086,333 | -90.881,167 | -12.765,695 | -4.587,736 | - | - | -100.000 |
Neuausgabe und Rückkäufe von Stammaktien | - | -106.786,852 | - | - | - | - | - | - | - |
Kennzahlen dieser Seite im Lexikon
Weitere Informationen findest du im Takani-Lexikon.